A recent WHO report underscores the “underrecognized” potential of vaccines to reduce antimicrobial resistance, a growing health crisis in which pathogens stop responding to antibiotics, resulting in nearly 5 million deaths worldwide in 2019.
The report evaluated current and upcoming vaccines, with vaccines in development — such as those for tuberculosis and Klebsiella pneumoniae — having the potential to prevent more than 500,000 antimicrobial resistance-related deaths.
The report also said expanding access to existing vaccines against pneumonia, typhoid and Haemopholis influenzae type B could curb antimicrobial resistance significantly.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
